Additionally, polymorphisms in genes such as ACE (angiotensin-converting enzyme), COL4A2 (type IV collagen alpha 2 chain), and MTHFR (methylenetetrahydrofolate reductase) have also been implicated in increasing the risk of hemorrhagic stroke [10]. This evidence concerns the gene MTHFR and hemorrhagic stroke.